1025 / 1851
Patient population
Histologically confirmed non-squamous NSCLC
Unresectable stage IIIA-IIIB disease
Surgically staged to confirm N2 or N3 disease
RTOG 1306 trial – “ALLIANCE”
Induction therapy with TKIs in “oncogene addicted” NSCLC
Future Perspectives…